ArticlePharmacoEconomics2016

Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial.

Lars Oddershede et al.PubMed ↗Publisher ↗

No numbers read from the abstract.